MX11339A - Una suspension acuosa estable con caracteristicas de liberacion retardada de carbamacepina y procedimiento para su preparacion - Google Patents

Una suspension acuosa estable con caracteristicas de liberacion retardada de carbamacepina y procedimiento para su preparacion

Info

Publication number
MX11339A
MX11339A MX1133988A MX1133988A MX11339A MX 11339 A MX11339 A MX 11339A MX 1133988 A MX1133988 A MX 1133988A MX 1133988 A MX1133988 A MX 1133988A MX 11339 A MX11339 A MX 11339A
Authority
MX
Mexico
Prior art keywords
carbamacepine
delay
procedure
preparation
stable water
Prior art date
Application number
MX1133988A
Other languages
English (en)
Inventor
Satish Chandra Khanna
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of MX11339A publication Critical patent/MX11339A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX1133988A 1987-05-04 1988-05-02 Una suspension acuosa estable con caracteristicas de liberacion retardada de carbamacepina y procedimiento para su preparacion MX11339A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH168287 1987-05-04

Publications (1)

Publication Number Publication Date
MX11339A true MX11339A (es) 1993-12-01

Family

ID=4216129

Family Applications (1)

Application Number Title Priority Date Filing Date
MX1133988A MX11339A (es) 1987-05-04 1988-05-02 Una suspension acuosa estable con caracteristicas de liberacion retardada de carbamacepina y procedimiento para su preparacion

Country Status (21)

Country Link
US (1) US5122543A (es)
EP (1) EP0289977B1 (es)
JP (1) JPH01131117A (es)
KR (1) KR960006059B1 (es)
AT (1) ATE94390T1 (es)
AU (1) AU619178B2 (es)
CA (1) CA1328219C (es)
DD (1) DD269784A5 (es)
DE (1) DE3884044D1 (es)
DK (1) DK169608B1 (es)
ES (1) ES2043716T3 (es)
FI (1) FI882044A (es)
HU (1) HU199074B (es)
IE (1) IE63081B1 (es)
IL (1) IL86211A (es)
MX (1) MX11339A (es)
NO (1) NO881933L (es)
NZ (1) NZ224476A (es)
PH (1) PH24895A (es)
PT (1) PT87381B (es)
ZA (1) ZA883135B (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE4210711A1 (de) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De Transdermale therapeutische systeme mit kristallisationsinhibitoren
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4422881A1 (de) * 1993-10-25 1995-04-27 Bayer Ag Kolloidal dispergierbare Wirkstoff-Formulierungen
ES2270426T3 (es) * 1994-03-18 2007-04-01 Supernus Pharmaceuticals, Inc. Sistema de suministros de farmacos emulsionados.
DE4423078B4 (de) * 1994-07-01 2005-01-13 Awd.Pharma Gmbh & Co. Kg Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
IL136807A0 (en) 1997-12-19 2001-06-14 Taro Pharmaceuticals Usa Inc Topical carbamazepine formulation and methods of use
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
IL156310A0 (en) * 2000-12-22 2004-01-04 Baxter Int Method for preparing submicron particle suspensions
US20040022862A1 (en) * 2000-12-22 2004-02-05 Kipp James E. Method for preparing small particles
US7193084B2 (en) * 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US8067032B2 (en) * 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US6884436B2 (en) * 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US6951656B2 (en) * 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US6869617B2 (en) * 2000-12-22 2005-03-22 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US9700866B2 (en) * 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US20040256749A1 (en) * 2000-12-22 2004-12-23 Mahesh Chaubal Process for production of essentially solvent-free small particles
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US6977085B2 (en) * 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
IN190699B (es) 2001-02-02 2003-08-16 Sun Pharmaceutical Ind Ltd
BR0212833A (pt) * 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US20060003012A9 (en) * 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
US7112340B2 (en) * 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
WO2003075830A2 (en) * 2002-03-14 2003-09-18 Sun Pharmaceutical Industries Limited Oral controlled drug delivery system containing carbamazepine
US20060280787A1 (en) * 2005-06-14 2006-12-14 Baxter International Inc. Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
BRPI0612071A2 (pt) * 2005-06-14 2010-10-19 Baxter Int formulações farmacêuticas para minimizar interações entre fármacos
JP2009516003A (ja) * 2005-11-15 2009-04-16 バクスター・インターナショナル・インコーポレイテッド リポキシゲナーゼ阻害剤の組成物
WO2008080047A2 (en) * 2006-12-23 2008-07-03 Baxter International Inc. Magnetic separation of fine particles from compositions
US8722736B2 (en) * 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US20080293814A1 (en) * 2007-05-22 2008-11-27 Deepak Tiwari Concentrate esmolol
US8426467B2 (en) * 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
US9394327B1 (en) * 2013-03-15 2016-07-19 The Trustees Of California State University Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins
CN107206097A (zh) * 2014-11-18 2017-09-26 皮克萨尔比奥公司 用于治疗急性、术后或慢性疼痛的组合物及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2861920A (en) * 1954-05-04 1958-11-25 Upjohn Co Therapeutic suspensions of steroids containing pvp and/or pva
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4431641A (en) * 1980-10-17 1984-02-14 Ciba-Geigy Corporation Pharmaceutical compositions having antiepileptic and antineuralgic action
CH649080A5 (de) * 1981-04-16 1985-04-30 Ciba Geigy Ag 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz.
JPS59147374A (ja) * 1983-02-10 1984-08-23 Fuji Xerox Co Ltd 電子写真複写機のブラシクリ−ニング方法
DE3306250A1 (de) * 1983-02-23 1984-08-23 Basf Ag, 6700 Ludwigshafen Sphaerische einkristalle fuer pharmazeutische zwecke
US4548990A (en) * 1983-08-15 1985-10-22 Ciba-Geigy Corporation Crosslinked, porous polymers for controlled drug delivery
EP0200213B1 (en) * 1985-05-02 1992-07-22 Ciba-Geigy Ag Hydrogels with increased organic solvent soluble active agent loading capacity, their preparation and the use thereof
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
JPH0641286B2 (ja) * 1987-05-14 1994-06-01 信行 西井 自動包装装置
US4964606A (en) * 1989-10-26 1990-10-23 Ncr Corporation Overhead mount for a CRT

Also Published As

Publication number Publication date
JPH01131117A (ja) 1989-05-24
IL86211A (en) 1992-03-29
DK238888A (da) 1988-11-05
DK238888D0 (da) 1988-05-03
ZA883135B (en) 1988-11-07
KR960006059B1 (ko) 1996-05-08
ES2043716T3 (es) 1994-01-01
US5122543A (en) 1992-06-16
EP0289977A1 (de) 1988-11-09
DE3884044D1 (de) 1993-10-21
HUT46847A (en) 1988-12-28
NO881933D0 (no) 1988-05-03
FI882044A0 (fi) 1988-05-02
AU619178B2 (en) 1992-01-23
ATE94390T1 (de) 1993-10-15
PH24895A (en) 1990-12-26
CA1328219C (en) 1994-04-05
IE881328L (en) 1988-11-04
NO881933L (no) 1988-11-07
NZ224476A (en) 1990-09-26
IE63081B1 (en) 1995-03-22
FI882044A (fi) 1988-11-05
IL86211A0 (en) 1988-11-15
DD269784A5 (de) 1989-07-12
AU1555888A (en) 1988-11-10
KR880013550A (ko) 1988-12-21
HU199074B (en) 1990-01-29
PT87381A (pt) 1989-05-31
DK169608B1 (da) 1994-12-27
PT87381B (pt) 1992-08-31
EP0289977B1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
MX11339A (es) Una suspension acuosa estable con caracteristicas de liberacion retardada de carbamacepina y procedimiento para su preparacion
ES497534A0 (es) Perfeccionamientos introducidos en los procedimientos de preparacion de formas galenicas con accion retardada y libera- cion programada.
DK663289A (da) Cellulaer struktur samt fremgangsmaade til fremstilling af samme
DK81789D0 (da) Fremgangsmaade til konservering af transplanterbare epithellag, som er dyrket in vitro
NO161513C (no) Fremgangsmaate til fremstilling av enkeltkrystallmaterialemed kontrollert krystallografisk orientering.
IT8419746A0 (it) Miscela di macinazione eprocedimento per la preparazione di una sospensione della stessa.
NO885411D0 (no) Fremgangsmaate for fremstilling av klordioksyd og natriumhydroksyd.
SE418166B (sv) Forfarande for framstellning av natriumperkarbonat i formar regelbundna romboedriska kristaller
IT1163640B (it) Procedimento di isomerizzazione con l'uso di glucosio isomerasi
DE3871385D1 (de) Fluessigkristallzubereitung.
RO89124A (ro) Procedeu pentru prepararea unor derivati de chinolona
AU3126084A (en) Crystal oscillator amplification
PT86764A (pt) Process for the increase the efficiency of in vitro vegetative propagation of potato
ES2024492B3 (es) Proceso para la preparacion de fibras de celulosa con una cadena insertada de hidrobarbil.
IT8423216A0 (it) Procedimento per produrre intermedi utili nella preparazione di derivati di 7-ossabicicloeptanprostaglandina.
DE3876983D1 (de) Fluessigkristallzubereitung.
IT8723302A0 (it) Procedimento per la decorazione di vetri e cristalli e cristalli decorati, in tale modo ottenuti.
KR900009464A (ko) GaAs단결정 성장방법
AR243231A1 (es) Procedimiento para producir medios de cultivo.
FR2634197B1 (fr) Procede de preparation de n-alkyl n(prime)-phenylparaphenylenediamines
FR2634198B1 (fr) Procede de preparation de n-alkyl n(prime)-phenylparaphenylenediamines
JPS5384591A (en) Crystal oscillator
NO890130L (no) Blanding for anvendelse ved fremstilling av stoepeformer.
ITPD930193A1 (it) Materasso globale con quattro superfici di dormita contenente due distinti materassi (con proprio contenitore) compositi questi ultimi
IT8721771A0 (it) Derivati penicillanici 2-tiosostituiti e procedimento di preparazione.